Capital Bank & Trust’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Capital Bank & Trust’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-900	Closed	-$1K	–	825
2019 Q4	$1K	Buy	+900	New	+$691	﹤0.01%	703

Capital Bank & Trust's GCVRZ Position: Q1 2020 in Review

Capital Bank & Trust sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 900 shares — an estimated $1K sold.

Capital Bank & Trust first reported a position in GCVRZ in Q4 2019 and held it in 1 quarter. The position peaked at $1K in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

Capital Bank & Trust reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
Capital Bank & Trust sold 900 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $1K.
Capital Bank & Trust first reported a position in Sanofi Contingent Value Rights in Q4 2019 and held it in 1 quarter.
Capital Bank & Trust's Sanofi Contingent Value Rights position peaked at $1K in Q4 2019.
2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Capital Bank & Trust's 13F filing for Q1 2020, filed 15 May 2020.